Pfizer-BioNTech Set To Supply The US Government With 105 Million COVID-19 Vaccine For US$3.2 Billion
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced on Wednesday a new vaccine supply agreement with the US
Read more
BioNTech
BioNTech Sees Vaccine Sales Push Q1 Revenues To €6.4 Billion
While many may view the pandemic as being over, the financial results of BioNTech (NASDAQ: BNTX) continue to say otherwise.
Read more
BioNTech Ends Q3 2021 With €6.1 Billion In Revenue
BioNTech SE (Nasdaq: BNTX) reported today its financial results for Q3 2021, highlighting quarterly revenue of €6.1 billion. This figure
Read more
BioNTech Sent Plummeting Following Damning Whistleblower Report, News of Covid-19 Pills
Shares of BioNTech (NASDAQ: BNTX) were sent into a nosedive on Friday, after a whistleblower report made scathing revelations surrounding
Read more
Pfizer-BioNTech COVID-19 Vaccine Trial For Ages 5-11 Returns Favorable Topline Results
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced this morning the topline results coming from its phase 2/3
Read more